These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24574356)

  • 41. Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes.
    Olsson M; Schnecke V; Cabrera C; Skrtic S; Lind M
    Diabetes Care; 2015 Aug; 38(8):1481-6. PubMed ID: 26015559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
    Mácsai E; Rakk E; Miléder M; Fulcz A
    Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea.
    Lee MJ; Kwon YE; Park KS; Kee YK; Yoon CY; Han IM; Han SG; Oh HJ; Park JT; Han SH; Yoo TH; Kim YL; Kim YS; Yang CW; Kim NH; Kang SW
    Medicine (Baltimore); 2016 Mar; 95(11):e3118. PubMed ID: 26986162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis.
    Hill CJ; Maxwell AP; Cardwell CR; Freedman BI; Tonelli M; Emoto M; Inaba M; Hayashino Y; Fukuhara S; Okada T; Drechsler C; Wanner C; Casula A; Adler AI; Lamina C; Kronenberg F; Streja E; Kalantar-Zadeh K; Fogarty DG
    Am J Kidney Dis; 2014 Jan; 63(1):84-94. PubMed ID: 23958400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access.
    García-Cantón C; Rufino-Hernández JM; Vega-Díaz N; Pérez-Borges P; Bosch-Benítez-Parodi E; Saavedra P; García-Gómez C; Marrero-Robayna S; Maceira-Cruz B; Rodríguez-Pérez JC; Checa-Andrés MD
    Nefrologia; 2013; 33(5):629-39. PubMed ID: 24089154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
    Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors in Brazilian diabetic patients starting dialysis: a 3.6-year follow-up study.
    Bruno RM; Gross JL
    J Diabetes Complications; 2000; 14(5):266-71. PubMed ID: 11113689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry.
    Yamagata K; Nakai S; Iseki K; Tsubakihara Y;
    Ther Apher Dial; 2012 Apr; 16(2):111-20. PubMed ID: 22458388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
    Sugawara A; Kawai K; Motohashi S; Saito K; Kodama S; Yachi Y; Hirasawa R; Shimano H; Yamazaki K; Sone H
    Diabetologia; 2012 Aug; 55(8):2128-31. PubMed ID: 22580991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: the Romanian Renal Registry.
    Mircescu G; Stefan G; Gârneaţă L; Mititiuc I; Siriopol D; Covic A
    Int Urol Nephrol; 2014 Feb; 46(2):443-51. PubMed ID: 24162889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure.
    Sens F; Schott-Pethelaz AM; Labeeuw M; Colin C; Villar E
    Kidney Int; 2011 Nov; 80(9):970-977. PubMed ID: 21775972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
    Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
    Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Better outcomes of peritoneal dialysis in diabetic patients in spite of risk of loss of autonomy for home dialysis.
    Cotovio P; Rocha A; Carvalho MJ; Teixeira L; Mendonça D; Cabrita A; Rodrigues A
    Perit Dial Int; 2014; 34(7):775-80. PubMed ID: 24385330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A1C and survival in maintenance hemodialysis patients.
    Kalantar-Zadeh K; Kopple JD; Regidor DL; Jing J; Shinaberger CS; Aronovitz J; McAllister CJ; Whellan D; Sharma K
    Diabetes Care; 2007 May; 30(5):1049-55. PubMed ID: 17337501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UK Renal Registry 15th annual report: Chapter 5 survival and causes of death of UK adult patients on renal replacement therapy in 2011: national and centre-specific analyses.
    Steenkamp R; Shaw C; Feest T
    Nephron Clin Pract; 2013; 123 Suppl 1():93-123. PubMed ID: 23774488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.